Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6281223

COc1ccc(CN2CCC3(C2)NCCc2c3[nH]c3ccc(OC)cc23)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CFTR P13569 20/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6281891 0.89 CFTR (0.59) CFTR
SCHEMBL6279000 0.88 CFTR (0.89) CFTR
Trifluoroacetic Acid SCHEMBL6504281 0.87 CFTR (0.57) CFTR
Trifluoroacetic Acid SCHEMBL6504278 0.87 CFTR (0.57) CFTR
Hydrochloric Acid SCHEMBL6279871 0.87 CFTR (0.88) CFTR
Trifluoroacetic Acid SCHEMBL6279019 0.87 CFTR (0.65) CFTR
Trifluoroacetic Acid SCHEMBL6279040 0.86 CFTR (0.64) CFTR
Trifluoroacetic Acid SCHEMBL6494633 0.86 CFTR (0.58) CFTR
SCHEMBL6494903 0.86 CFTR (0.70) CFTR
Trifluoroacetic Acid SCHEMBL6280982 0.85 CFTR (0.63) CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288316-A1 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists BIOVITRUM AB (SE) 2005-12-29 US claimed
WO-2005048916-A2 TETRAHYDROSPIRO-BETA-CARBOLINE-1,3 '-PYRROLIDINE DERIVATIVES AND THEIR USE IN GHSR-RELATED DISORDERS BIOVITRUM AB (SE) 2005-06-02 WO claimed
US-6884821-B1 Carboxylic acid derivatives and drugs containing the same EISAI CO., LTD. (JP) 2005-04-26 US disclosed
EP-1216980-A1 CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME Eisai Co., Ltd. (JP) 2002-06-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288316-A1 Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists GHSR, GHRHR, PRLHR CFTR 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.